References
- Michaelson I. C. Diabetic retinopathy. Textbook of fundus of the eye, Livingstone Churchill, 1980; 876
- Heath H., Bridgen W. D., Canever J. V., Pollack J., Hunter P. R., Kesley J., Bloom A. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologica 1971; 7: 308–315
- Dobbie J. G., Kwaan H. C., Colwell J., Suwanwela N. Role of platelets in pathogenesis of diabetic retinopathy. Arch. Ophthal. 1974; 91: 107–109
- Brownlee M., Chaill G. F. Diabetic control and vascular complications. Artheriosclerosis Reviews, R. Paoletti. Raven Press, New York 1979; Vol. 4: 29–70
- Halushka P. V., Lurie D., Colwell D. J. Increased synthesis of prostaglandin E-like material by platelets from patients with diabetes mellitus. New Eng. J. Med. 1977; 297: 1305–1310
- Colwell J. A., Halushka P. V., Sarji K., Levine J., Sagel J., Nair P. R.S. Altered platelet function in diabetes mellitus Diabetes 1976; 15: 826–831
- Kwaan H. C., Colwell J. A., Cruz S., et al. Increased platelet aggregation in diabetes mellitus. J. Lab. Clin. Med. 1972; 80: 236–239
- Halushka P. V., Colwell J. A., Rogers C., Loadholt C. B., et al. Increased thromboxane synthesis by platelets from patients with diabetes mellitus; studied with a thromboxane synthetase inhibitor and thromboxane antagonist. Clin. Res. 1979; 27: 296A
- Johnson M., Harrison H. E., et al. Va Vascular prostacyclin may be reduced in diabetes in man. Lancet 1975; 1: 320
- Silberbauer K., Scherwthaner G., Sinzinger H., Piza-Katzek H., Winter M. Decreased vascular prostacyclin in juvenile-onset diabetes. New Engl. J. Med. 1979; 300: 366
- Rosen P., Schror K. Increased rp prostacyclin release from perfused hearts of acutely diabetic rats. Diabetologica 1980; 18: 391–394
- Johnson M., Reece A. H., Harrison H. E. An imbalance in arachidonic acid metabolism in diabetes. Advances in prostaglandins and thromboxane research, B. Samuelson, P. W. Ramwell, P. Paoletti. Raven Press, New York 1980; Vol. 6: 1283–1286
- Hoult J. R.S., Moore P. K. Prostaglandin synthesis and inactivation in kidneys and lungs of rats with experimental diabetes. Clin. Res. 1980; 59: 63–66
- Gerrard J. A., Stuart M. J., Gundu H. R.R., Steffes M. W., Mauer M., Brown D. M., White J. G. Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J. Lab. Clin. Med. 1980; 95: 950–958
- Papachristodonlou D., Heath H. Ultrastructural alterations during the development of retinopathy in sucrose-fed and streptozotocin-diabetic rats. Exp. Eye Res. 1977; 25: 371–384
- Bauminger S., Zor U., Linder H. R. Radioimmunological assay of prostaglandin synthetase activity. Prostaglandins 1974; 4: 313–324
- Dollery C. T., Friedman L. A., Hensby C. M., Kohner E., Lewis P. J., Porta M., Webster J. Circulating prostacyclin may be reduced in diabetes. Lancet 1979; 11: 1365
- Davies T. M.L., Mitchel M. D., Turner R. C. Prostacyclin and thromboxane metabolism in diabetes. Lancet 1979; 11: 789–790
- Naveh-Floman N. Prostacyclin synthesis in diabetic retinopathy, ARVO 1983, Suppl to Invest. Ophthal, Vis. Sci. 1983; 24: 251
- Bohlen H. G., Niggl B. A. Arteriolar anatomical and functional abnormalities in juvenile mice with genetic or streptozotocin-induced diabetes mellitus. Circulation Res. 1979; 45: 390
- Moncada S., Vane J. R. Arachidonic acid metabolites and the interactions between platelets and blood vessel walls. New Engl. J. Med. 1979; 300: 1142–1147